Management of the Cirrhotic Patient Before Liver Transplantation: The Role of the Referring Gastroenterologist.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 28289338)

Published in Gastroenterol Hepatol (N Y) on May 01, 2006


R Todd Stravitz1

Author Affiliations

1: Dr. Stravitz is Associate Professor of Medicine in the Section of Hepatology at Virginia Commonwealth University in Richmond, Va.

Articles cited by this

A model to predict survival in patients with end-stage liver disease. Hepatology (2001) 18.06

Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology (2003) 10.11

Fulminant hepatitis associated with hepatitis A virus superinfection in patients with chronic hepatitis C. N Engl J Med (1998) 5.90

Hepatocellular carcinoma: recent trends in the United States. Gastroenterology (2004) 5.90

Randomized controlled trial of screening for hepatocellular carcinoma. J Cancer Res Clin Oncol (2004) 5.29

Resection and liver transplantation for hepatocellular carcinoma. Semin Liver Dis (2005) 4.51

Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices. A prospective multicenter study. N Engl J Med (1988) 3.53

The course of patients after variceal hemorrhage. Gastroenterology (1981) 3.33

Hepatitis C infection and the increasing incidence of hepatocellular carcinoma: a population-based study. Gastroenterology (2004) 3.30

Hepatocellular carcinoma: epidemiology, risk factors, and screening. Semin Liver Dis (2005) 2.98

Increased survival of cirrhotic patients with a hepatocellular carcinoma detected during surveillance. Gastroenterology (2004) 2.91

AASLD practice guidelines: Evaluation of the patient for liver transplantation. Hepatology (2005) 2.90

Incidence and natural history of small esophageal varices in cirrhotic patients. J Hepatol (2003) 2.46

Ligation versus propranolol for the primary prophylaxis of variceal bleeding in cirrhosis. Hepatology (2004) 2.45

Hepatic Encephalopathy. Am J Gastroenterol (2001) 2.37

Minimal hepatic encephalopathy impairs fitness to drive. Hepatology (2004) 2.20

Alpha-fetoprotein and ultrasonography screening for hepatocellular carcinoma. Gastroenterology (2004) 2.08

Management of adult patients with ascites due to cirrhosis. Hepatology (2004) 2.05

Comparison of endoscopic ligation and propranolol for the primary prevention of variceal bleeding. N Engl J Med (1999) 1.98

Obesity and its effect on survival in patients undergoing orthotopic liver transplantation in the United States. Hepatology (2002) 1.98

Natural history of portal hypertension in patients with cirrhosis. Clin Liver Dis (2001) 1.91

Comparison of rifaximin and lactitol in the treatment of acute hepatic encephalopathy: results of a randomized, double-blind, double-dummy, controlled clinical trial. J Hepatol (2003) 1.90

AGA technical review on osteoporosis in hepatic disorders. Gastroenterology (2003) 1.89

Hepatorenal syndrome. Lancet (2003) 1.86

Semiannual and annual surveillance of cirrhotic patients for hepatocellular carcinoma: effects on cancer stage and patient survival (Italian experience). Am J Gastroenterol (2002) 1.85

Risk factors for the development of bacterial infections in hospitalized patients with cirrhosis. Am J Gastroenterol (1999) 1.82

Screening for hepatocellular carcinoma in chronic carriers of hepatitis B virus: incidence and prevalence of hepatocellular carcinoma in a North American urban population. Hepatology (1995) 1.76

Impact of large regenerative, low grade and high grade dysplastic nodules in hepatocellular carcinoma development. J Hepatol (2003) 1.74

Natural history of small untreated hepatocellular carcinoma in cirrhosis: a multivariate analysis of prognostic factors of tumor growth rate and patient survival. Hepatology (1992) 1.72

Norfloxacin prevents spontaneous bacterial peritonitis recurrence in cirrhosis: results of a double-blind, placebo-controlled trial. Hepatology (1990) 1.63

Treatment of hepatic encephalopathy with metronidazole. Gut (1982) 1.61

Risk of a first community-acquired spontaneous bacterial peritonitis in cirrhotics with low ascitic fluid protein levels. Gastroenterology (1999) 1.59

Trimethoprim-sulfamethoxazole for the prevention of spontaneous bacterial peritonitis in cirrhosis: a randomized trial. Ann Intern Med (1995) 1.59

Cigarette smoking is associated with an increased incidence of vascular complications after liver transplantation. Liver Transpl (2002) 1.57

Tobacco use following liver transplantation for alcoholic liver disease: an underestimated problem. Liver Transpl (2005) 1.55

Rifaximin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic potential in conditions mediated by gastrointestinal bacteria. Drugs (1995) 1.45

Paracentesis-induced circulatory dysfunction: mechanism and effect on hepatic hemodynamics in cirrhosis. Gastroenterology (1997) 1.43

Hepatic encephalopathy: An update of pathophysiologic mechanisms. Proc Soc Exp Biol Med (1999) 1.36

Beta-adrenergic antagonists in the prevention of gastrointestinal rebleeding in patients with cirrhosis: a meta-analysis. Hepatology (1997) 1.33

Comparison of paracentesis and diuretics in the treatment of cirrhotics with tense ascites. Results of a randomized study. Gastroenterology (1987) 1.23

The diagnosis and prevalence of subclinical hepatic encephalopathy in apparently healthy, ambulant, non-shunted patients with cirrhosis. J Hepatol (1986) 1.16

Prevalence and prediction of osteopenia in chronic liver disease. Hepatology (1990) 1.15

Local/regional and systemic treatments of hepatocellular carcinoma. Semin Liver Dis (2005) 1.13

Deafness complicating antibiotic therapy of hepatic encephalopathy. Ann Intern Med (1970) 1.10

Fulminant hepatitis A in intravenous drug users with chronic liver disease. Ann Intern Med (1989) 1.09

Treatment of osteomalacia associated with primary biliary cirrhosis with parenteral vitamin D2 or oral 25-hydroxyvitamin D3. Gut (1979) 1.06

Ciprofloxacin and long-term prevention of spontaneous bacterial peritonitis: results of a prospective controlled trial. Hepatology (1995) 1.04

Malnutrition in liver transplant patients: preoperative subjective global assessment is predictive of outcome after liver transplantation. Transplantation (2001) 1.04

Metronidazole pharmacokinetics in patients with hepatic encephalopathy. Scand J Gastroenterol (1987) 1.01

Inhibitory effect of alcohol on osteogenic differentiation in human bone marrow-derived mesenchymal stem cells. Alcohol Clin Exp Res (2004) 0.99

The effect of high dose and short interval HBV vaccination in individuals with chronic hepatitis C. Am J Gastroenterol (2002) 0.96

Bone disease in primary biliary cirrhosis: reversal of osteomalacia with oral 25-hydroxyvitamin D. Gastroenterology (1980) 0.95

Non-lymphoid cancer after liver transplantation. Hepatogastroenterology (1997) 0.94

Presence of bacterial infection in bleeding cirrhotic patients is independently associated with early mortality and failure to control bleeding. Dig Dis Sci (2001) 0.94

Beneficial effects of intravenous albumin infusion on the hemodynamic and humoral changes after total paracentesis. Hepatology (1995) 0.93

Endoscopic treatments for portal hypertension. Semin Liver Dis (1999) 0.92

Vaccination against hepatitis B virus in cirrhotic patients on liver transplant waiting list. Liver Transpl (2000) 0.92

American Gastroenterological Association medical position statement: osteoporosis in hepatic disorders. Gastroenterology (2003) 0.92

Management of cirrhosis due to chronic hepatitis C. J Hepatol (2005) 0.92

Tumors and transplantation: The 2003 Third Annual ASTS State-of-the-Art Winter Symposium. Am J Transplant (2003) 0.91

Issues of malnutrition and bone disease in patients with cirrhosis. J Gastroenterol Hepatol (2002) 0.91

Immunogenicity of hepatitis A vaccination in decompensated cirrhotic patients. Hepatology (2001) 0.88

Alendronate is more effective than etidronate for increasing bone mass in osteopenic patients with primary biliary cirrhosis. Am J Gastroenterol (2003) 0.87

Bone density and metabolism in patients with viral hepatitis and cholestatic liver diseases before and after liver transplantation. Am J Gastroenterol (2000) 0.85

Estrogen-progestogen therapy for low bone mineral density in primary biliary cirrhosis. Liver (1999) 0.84

Spironolactone pharmacokinetics and pharmacodynamics in patients with cirrhotic ascites. Gastroenterology (1992) 0.82

Natural history of cirrhotic patients with small esophageal varices: a prospective study. Am J Gastroenterol (2000) 0.82

Primary prophylaxis of variceal hemorrhage. Clin Liver Dis (2001) 0.81

Management of pre-liver transplantation patient--part 2. Liver Transpl (2005) 0.80

Liver disease, aminoglycoside antibiotics and renal dysfunction. Hepatology (1988) 0.80

The importance of the highest normokalemia in the treatment of early hepatic encephalopathy. Miner Electrolyte Metab (1993) 0.80

Randomized clinical study of the efficacy of amiloride and potassium canrenoate in nonazotemic cirrhotic patients with ascites. Hepatology (1994) 0.79

Eplerenone: a selective aldosterone receptor antagonist for patients with heart failure. Ann Pharmacother (2004) 0.78

Management of pre-liver transplantation patients--part 1. Liver Transpl (2005) 0.76